These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 23242600)
1. Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations. Scottà C; Esposito M; Fazekasova H; Fanelli G; Edozie FC; Ali N; Xiao F; Peakman M; Afzali B; Sagoo P; Lechler RI; Lombardi G Haematologica; 2013 Aug; 98(8):1291-9. PubMed ID: 23242600 [TBL] [Abstract][Full Text] [Related]
2. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro. Singh AK; Horvath KA; Mohiuddin MM Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569 [TBL] [Abstract][Full Text] [Related]
3. Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells. Candia E; Reyes P; Covian C; Rodriguez F; Wainstein N; Morales J; Mosso C; Rosemblatt M; Fierro JA PLoS One; 2017; 12(7):e0182009. PubMed ID: 28746369 [TBL] [Abstract][Full Text] [Related]
4. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid. Lu L; Zhou X; Wang J; Zheng SG; Horwitz DA PLoS One; 2010 Dec; 5(12):e15150. PubMed ID: 21179414 [TBL] [Abstract][Full Text] [Related]
5. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841 [TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate. Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923 [TBL] [Abstract][Full Text] [Related]
7. Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment. Schliesser U; Chopra M; Beilhack A; Appelt C; Vogel S; Schumann J; Panov I; Vogt K; Schlickeiser S; Olek S; Wood K; Brandt C; Volk HD; Sawitzki B Eur J Immunol; 2013 Dec; 43(12):3291-305. PubMed ID: 23946112 [TBL] [Abstract][Full Text] [Related]
8. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. Strauss L; Whiteside TL; Knights A; Bergmann C; Knuth A; Zippelius A J Immunol; 2007 Jan; 178(1):320-9. PubMed ID: 17182569 [TBL] [Abstract][Full Text] [Related]
9. Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells. Singh M; Basu S; Camell C; Couturier J; Nudelman RJ; Medina MA; Rodgers JR; Lewis DE Eur J Immunol; 2008 Jun; 38(6):1522-32. PubMed ID: 18446791 [TBL] [Abstract][Full Text] [Related]
10. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus. Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033 [TBL] [Abstract][Full Text] [Related]
11. CD4(+)CD25(-)Nrp1(+) T cells synergize with rapamycin to prevent murine cardiac allorejection in immunocompetent recipients. Yuan Q; Hong S; Shi B; Kers J; Li Z; Pei X; Xu L; Wei X; Cai M PLoS One; 2013; 8(4):e61151. PubMed ID: 23577203 [TBL] [Abstract][Full Text] [Related]
12. Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-α. Goldberg R; Scotta C; Cooper D; Nissim-Eliraz E; Nir E; Tasker S; Irving PM; Sanderson J; Lavender P; Ibrahim F; Corcoran J; Prevost T; Shpigel NY; Marelli-Berg F; Lombardi G; Lord GM Gastroenterology; 2019 May; 156(6):1775-1787. PubMed ID: 30710527 [TBL] [Abstract][Full Text] [Related]
13. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin. Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839 [TBL] [Abstract][Full Text] [Related]
15. Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4 Hu M; Hawthorne WJ; Nicholson L; Burns H; Qian YW; Liuwantara D; Jimenez Vera E; Chew YV; Williams L; Yi S; Keung K; Watson D; Rogers N; Alexander SI; O'Connell PJ Diabetes; 2020 Aug; 69(8):1735-1748. PubMed ID: 32381646 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors. Moore C; Sauma D; Morales J; Bono MR; Rosemblatt M; Fierro JA Transplant Proc; 2009; 41(6):2670-2. PubMed ID: 19715998 [TBL] [Abstract][Full Text] [Related]
17. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
18. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Battaglia M; Stabilini A; Draghici E; Migliavacca B; Gregori S; Bonifacio E; Roncarolo MG Diabetes; 2006 Jun; 55(6):1571-80. PubMed ID: 16731819 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. Golovina TN; Mikheeva T; Brusko TM; Blazar BR; Bluestone JA; Riley JL PLoS One; 2011 Jan; 6(1):e15868. PubMed ID: 21253593 [TBL] [Abstract][Full Text] [Related]
20. CD8 Chen J; Zhuang L; Li Y; Wu K; Duan Y; Feng J; Sun D; Qu Z; Shi L Transpl Immunol; 2023 Apr; 77():101805. PubMed ID: 36841514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]